HEATHER GLOVER: Open Payments
NPI 1265794564 · BONO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$213 in 7 payments from 5 companies in 2025. Trend: 2023 $251 · 2024 $422 · 2025 $213
Food & beverage: $213
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $87 |
| ABBVIE INC. | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: CAPLYTA, QULIPTA, ABILIFY ASIMTUFII, Auvelity, VRAYLAR, INGREZZA.
Industry payments across AR — which companies pay providers there.
